Can Sarisozen (C Sarisozen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2019
Publications (10 Years): 4

Top Topics

Hyaluronic Acid

Induced Apoptosis

Top Venues

Journal of drug targeting

Pharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Can Sarisozen, Y Tan, J Liu, C Bilir, L Shen, N Filipczak, T M Porter, V P Torchilin
MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation. Journal of drug targeting 27 (5-6) (2019)
Livia P Mendes, Can Sarisozen, Ed Luther, Jiayi Pan, Vladimir P Torchilin
Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers. Drug delivery 26 (1) (2019)
Nina Filipczak, Anna Jaromin, Adriana Piwoni, Mohamed Mahmud, Can Sarisozen, Vladimir Torchilin, Jerzy Gubernator
A Triple Co-Delivery Liposomal Carrier That Enhances Apoptosis via an Intrinsic Pathway in Melanoma Cells. Cancers 11 (12) (2019)
Yury A Vladimirov, Can Sarisozen, Georgy K Vladimirov, Nina Filipczak, Anastasia M Polimova, Vladimir P Torchilin
The Cytotoxic Action of Cytochrome C/Cardiolipin Nanocomplex (Cyt-CL) on Cancer Cells in Culture. Pharmaceutical research 34 (6) (2017)